| Literature DB >> 25617512 |
Abstract
According to data from the most recent edition of the Canadian Rx Atlas, Quebec was the province with the highest total spending per capita on prescription drugs. The difference between Quebec and the rest of Canada was 35%, which translates into $1.5 billion dollars of extra spending. This analysis explores the economic cost drivers of the higher level of pharmaceutical spending in Quebec. While much of the additional spending was driven by a higher volume of drugs being prescribed overall, the factors contributing to higher spending differed greatly within particular therapeutic categories. The results and their implications are discussed in the context of pharmaceutical policy environment.Mesh:
Substances:
Year: 2014 PMID: 25617512 PMCID: PMC4748354
Source DB: PubMed Journal: Healthc Policy ISSN: 1715-6572